Study of AT-527 in Subjects With Normal and Impaired Renal Function

Clinical trial NCT05618314 · COMPLETED

Trial details

NCT number: NCT05618314
Sponsor: Atea Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteer Renal Impairment

Start date: 2022-10-17
Primary completion: 2024-06-15
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.